Noromectin 1%
Back to products
Vermic Total
Click to enlarge

FELOCELL® 3

Zoetis

General information

target species

cat
usage

injectable
brand

Zoetis
manufacturer country

usa

Felocell 3 contains attenuated strains of feline rhinotracheitis virus, calicivirus, and panleukopenia virus (Johnson Snow Leopard strain), propagated in established cell lines.

This page is only to introduce the product for use by the authorized veterinary centers of the country and the sale is not done online. For more information and to order the product, please contact the company.

Product Description

  • Composition:
  • feline herpesvirus-1
  • feline calicivirus (FCV)
  • feline parvovirus (FPV)

 

·      Indications of use:

For vaccination of healthy cats as an aid in preventing feline viral rhinotracheitis (FVR) caused by feline herpesvirus-1, feline respiratory disease caused by feline calicivirus (FCV), and feline panleukopenia caused by feline parvovirus (FPV).

 

·      Dosage and route of administration:

  • General Directions: Vaccination of healthy cats is recommended. Aseptically rehydrate the freeze-dried vaccine with the sterile diluent provided, shake well, and administer 1 mL intramuscularly or subcutaneously.
  • Primary Vaccination: Healthy cats 12 weeks of age or older should receive 2 doses administered 3-4 weeks apart. Cats vaccinated at less than 12 weeks of age should be revaccinated at 12 weeks of age.
  • Revaccination: Annual revaccination with a single dose is recommended, although, as recommended by the American Veterinary Medical Association and its Council on Biologic and Therapeutic Agents, the attending veterinarian should determine the frequency of revaccination based on the animal’s lifestyle and risk of exposure.

  • Precautions and contraindications:
  • Sterilized syringes and needles should be used to administer this vaccine. Do not sterilize with chemicals because traces of disinfectant may inactivate the vaccine.
  • Contains gentamicin as preservative.
  • Vaccination of pregnant queens should be avoided.
  • As with many vaccines, anaphylaxis may occur after use. Initial antidote of epinephrine is recommended and should be followed with appropriate supportive therapy.
  • This product has been shown to be efficacious in healthy animals. A protective immune response may not be elicited if animals are incubating an infectious disease, are malnourished or parasitized, are stressed due to shipment or environmental conditions, are otherwise immunocompromised, or the vaccine is not administered in accordance with label directions.

 

 

  • Storage methods:

Store at 2°-8°C.

Prolonged exposure to higher temperatures and/or direct sunlight may adversely affect potency.

Do not freeze.

Use entire contents when first opened.

 

  • Presentation:

Available in 25 x 1 dose.

 

  • Manufacturer:

Zoetis , America

Product Information

target species

cat
usage

injectable
brand

Zoetis
manufacturer country

usa

Product Description

  • Composition:
  • feline herpesvirus-1
  • feline calicivirus (FCV)
  • feline parvovirus (FPV)

 

·      Indications of use:

For vaccination of healthy cats as an aid in preventing feline viral rhinotracheitis (FVR) caused by feline herpesvirus-1, feline respiratory disease caused by feline calicivirus (FCV), and feline panleukopenia caused by feline parvovirus (FPV).

 

·      Dosage and route of administration:

  • General Directions: Vaccination of healthy cats is recommended. Aseptically rehydrate the freeze-dried vaccine with the sterile diluent provided, shake well, and administer 1 mL intramuscularly or subcutaneously.
  • Primary Vaccination: Healthy cats 12 weeks of age or older should receive 2 doses administered 3-4 weeks apart. Cats vaccinated at less than 12 weeks of age should be revaccinated at 12 weeks of age.
  • Revaccination: Annual revaccination with a single dose is recommended, although, as recommended by the American Veterinary Medical Association and its Council on Biologic and Therapeutic Agents, the attending veterinarian should determine the frequency of revaccination based on the animal’s lifestyle and risk of exposure.

  • Precautions and contraindications:
  • Sterilized syringes and needles should be used to administer this vaccine. Do not sterilize with chemicals because traces of disinfectant may inactivate the vaccine.
  • Contains gentamicin as preservative.
  • Vaccination of pregnant queens should be avoided.
  • As with many vaccines, anaphylaxis may occur after use. Initial antidote of epinephrine is recommended and should be followed with appropriate supportive therapy.
  • This product has been shown to be efficacious in healthy animals. A protective immune response may not be elicited if animals are incubating an infectious disease, are malnourished or parasitized, are stressed due to shipment or environmental conditions, are otherwise immunocompromised, or the vaccine is not administered in accordance with label directions.

 

 

  • Storage methods:

Store at 2°-8°C.

Prolonged exposure to higher temperatures and/or direct sunlight may adversely affect potency.

Do not freeze.

Use entire contents when first opened.

 

  • Presentation:

Available in 25 x 1 dose.

 

  • Manufacturer:

Zoetis , America